Meghalaya Pharmacists Await Service Rules Even After 50 Years of Statehood Written By Susmita Roy2 Oct 2025 11:30 AM ISTNew Delhi: More than fifty years since Meghalaya became a state in 1972, service rules for pharmacists are yet to be finalised, creating a persistent...
SEC Recommends Phase III Trial of MSN Labs' Vibegron Against Mirabegron in Overactive Bladder Written By Parthika Patel2 Oct 2025 10:30 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended granting permission to MSN...
Health crisis in a bottle: Rajasthan govt bans cough syrup batch after patients fall ill in Bharatpur, Sikar Written By MD Bureau1 Oct 2025 7:00 PM ISTJaipur: The Rajasthan Medical Services Corporation Limited (RMSCL) has imposed a ban on the distribution and use of a batch of cough syrup...
Fake docs, real jobs: Pharmacist at Community Health Centre in Ballia booked in recruitment scam Written By Ruchika Sharma1 Oct 2025 2:18 PM ISTBallia: A pharmacist and a postal assistant have been booked after being accused of using fake appointment letters to secure government jobs...
Wockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative Infections Written By Ruchika Sharma1 Oct 2025 1:00 PM ISTMumbai: Wockhardt has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (US FDA) for its novel...
Biocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US Written By Ruchika Sharma1 Oct 2025 12:05 PM ISTBengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced a settlement...
Lupin bags USFDA approval for Rivaroxaban for Oral Suspension for thromboprophylaxis in pediatric patients Written By Ruchika Sharma1 Oct 2025 11:37 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
Indian Immunologicals Launches Raksha-IBR, India's First DIVA Vaccine Against IBR Written By Parthika Patel30 Sept 2025 3:24 PM ISTHyderabad: In a major breakthrough for the livestock sector, Indian Immunologicals Limited (IIL) has rolled out India's first gE-deleted DIVA marker...
Rajasthan Drug Official Under Probe for Misreporting Spurious Medicines Written By Parthika Patel30 Sept 2025 3:16 PM ISTJaipur: A senior official from Rajasthan's Food Safety and Drug Control Commissionerate (FSDCC) is under investigation for allegedly misreporting...
Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol Written By Farhat Nasim30 Sept 2025 3:09 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Intas Pharmaceuticals Ltd. to...
AbbVie to Launch Ovarian Cancer Drug ELAHERE in UK at US Price Levels Written By Parthika Patel30 Sept 2025 2:57 PM ISTNew Delhi: AbbVie has announced that it will launch its ovarian cancer drug ELAHERE (mirvetuximab soravtansine-gynx) in the United Kingdom at a list...
Kala Bio Halts Eye Drug Development After Phase 2b Trial Failure Written By Parthika Patel30 Sept 2025 2:49 PM ISTNew Delhi: KALA BIO, Inc. a clinical-stage biopharmaceutical company focused on eye diseases, announced that its CHASE Phase 2b trial for KPI-012 in...
